{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:48:43Z","timestamp":1793213323804,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T00:00:00Z","timestamp":1624665600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T00:00:00Z","timestamp":1624665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81970435"],"award-info":[{"award-number":["81970435"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012175","name":"Zhejiang Traditional Chinese Medicine Administration","doi-asserted-by":"publisher","award":["2018ZZ019"],"award-info":[{"award-number":["2018ZZ019"]}],"id":[{"id":"10.13039\/501100012175","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Special Project for Significant New Drug Research and Development in the Major National Science and Technology Projects of China","award":["2020ZX09201002"],"award-info":[{"award-number":["2020ZX09201002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Coronary artery lesions (CALs) are the most severe complication of Kawasaki disease (KD). Approximately 9\u201320% of the patients with KD develop CAL despite receiving regular treatment (intravenous immunoglobulin [IVIG] and aspirin). Some patients develop coronary aneurysms, leading to coronary artery stenosis or thrombosis, resulting in ischaemic heart disease and significantly affect the patients\u2019 lives. The purpose of this study was to investigate the factors associated with the duration of CAL in patients with KD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The data of 464 patients with KD and CAL admitted to the Children\u2019s Heart Centre, The Second Affiliated Hospital and Yuying Children\u2019s Hospital from 2010 to 2018 were retrospectively analysed. Demographic and clinical information and echocardiographic follow-up data were collected. Kaplan\u2013Meier curves were used to estimate the overall CAL duration, and the log-rank test was used to compare statistical differences. Univariate and multivariate Cox regression models were used to identify variables related to the CAL duration.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The median CAL duration was 46\u2009days (95% confidence interval: 41\u201354\u2009days). CALs were observed in 61.5, 41.5, 33.3, 22.3, 10.3, and 7.7% of the patients at 1\u2009month, 2\u2009months, 3\u2009months, 6\u2009months, 1\u2009year, and 2\u2009years after the onset of KD, respectively. Univariate Cox regression model showed that sex (<jats:italic>p<\/jats:italic>\u00a0=\u20090.016), rash symptoms (<jats:italic>p<\/jats:italic>\u00a0=\u20090.035), delayed IVIG treatment (<jats:italic>p<\/jats:italic>\u00a0=\u20090.022), CAL type (<jats:italic>p<\/jats:italic>\u00a0&lt;\u20090.001), degree of CAL (<jats:italic>p<\/jats:italic>\u00a0&lt;\u20090.001), white blood cell count before IVIG treatment (<jats:italic>p<\/jats:italic>\u00a0=\u20090.019), and platelet count after IVIG treatment (<jats:italic>p<\/jats:italic>\u00a0=\u20090.003) were statistically significant factors associated with the overall CAL duration. Multivariable Cox regression showed that delayed IVIG treatment (<jats:italic>p<\/jats:italic>\u00a0=\u20090.020), multiple dilatations (<jats:italic>p<\/jats:italic>\u00a0&lt;\u20090.001), a greater degree of dilatation (<jats:italic>p<\/jats:italic>\u00a0&lt;\u20090.001), and higher platelet count after IVIG treatment (<jats:italic>p<\/jats:italic>\u00a0=\u20090.007) were positively related to CAL duration.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>CAL duration was affected by delayed IVIG treatment, type of CAL, degree of CAL, and platelet count after IVIG treatment. These factors should be monitored carefully during the follow-up and management of patients with KD and CAL.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12969-021-00589-z","type":"journal-article","created":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T21:15:48Z","timestamp":1624742148000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Factors affecting the duration of coronary artery lesions in patients with the Kawasaki disease: a retrospective cohort study"],"prefix":"10.1186","volume":"19","author":[{"given":"Xuting","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuee","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiping","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biyao","family":"Hang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhipeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0975-7176","authenticated-orcid":false,"given":"Maoping","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,26]]},"reference":[{"key":"589_CR1","doi-asserted-by":"publisher","first-page":"e927","DOI":"10.1161\/CIR.0000000000000484","volume":"135","author":"BW McCrindle","year":"2017","unstructured":"McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, et al. Diagnosis, treatment, and long-term Management of Kawasaki Disease: a scientific statement for health professionals from the American Heart Association. Circulation. 2017;135:e927\u2013e99.","journal-title":"Circulation."},{"issue":"8","key":"589_CR2","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1253\/circj.CJ-19-1094","volume":"84","author":"R Fukazawa","year":"2020","unstructured":"Fukazawa R, Kobayashi J, Ayusawa M, Hamada H, Miura M, Mitani Y, et al. JCS\/JSCS 2020 guideline on diagnosis and Management of Cardiovascular Sequelae in Kawasaki disease. Circ J. 2020;84(8):1348\u2013407. https:\/\/doi.org\/10.1253\/circj.CJ-19-1094.","journal-title":"Circ J"},{"issue":"10","key":"589_CR3","doi-asserted-by":"publisher","first-page":"429","DOI":"10.2188\/jea.JE20190065","volume":"30","author":"LP Xie","year":"2020","unstructured":"Xie LP, Yan WL, Huang M, Huang MR, Chen S, Huang GY, et al. Epidemiologic features of Kawasaki disease in Shanghai from 2013 through 2017. J Epidemiol. 2020;30(10):429\u201335. https:\/\/doi.org\/10.2188\/jea.JE20190065.","journal-title":"J Epidemiol."},{"key":"589_CR4","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.jpeds.2018.07.090","volume":"203","author":"SM Skochko","year":"2018","unstructured":"Skochko SM, Jain S, Sun X, Sivilay N, Kanegaye JT, Pancheri J, et al. Kawasaki disease outcomes and response to therapy in a multiethnic community: a 10-year experience. J Pediatr. 2018;203:408\u201315 e3. https:\/\/doi.org\/10.1016\/j.jpeds.2018.07.090.","journal-title":"J Pediatr"},{"key":"589_CR5","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jpeds.2020.05.034","volume":"225","author":"R Ae","year":"2020","unstructured":"Ae R, Makino N, Kosami K, Kuwabara M, Matsubara Y, Nakamura Y. Epidemiology, treatments, and cardiac complications in patients with Kawasaki disease: the Nationwide survey in Japan, 2017-2018. J Pediatr. 2020;225:23\u20139 e2. https:\/\/doi.org\/10.1016\/j.jpeds.2020.05.034.","journal-title":"J Pediatr"},{"issue":"7","key":"589_CR6","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1007\/s00246-014-0926-2","volume":"35","author":"M Fujino","year":"2014","unstructured":"Fujino M, Hata T, Kuriki M, Horio K, Uchida H, Eryu Y, et al. Inflammation aggravates heterogeneity of ventricular repolarization in children with Kawasaki disease. Pediatr Cardiol. 2014;35(7):1268\u201372. https:\/\/doi.org\/10.1007\/s00246-014-0926-2.","journal-title":"Pediatr Cardiol"},{"issue":"5","key":"589_CR7","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2018.0030","volume":"172","author":"M Miura","year":"2018","unstructured":"Miura M, Kobayashi T, Kaneko T, Ayusawa M, Fukazawa R, Fukushima N, et al. Association of Severity of coronary artery aneurysms in patients with Kawasaki disease and risk of later coronary events. JAMA Pediatr. 2018;172(5):e180030. https:\/\/doi.org\/10.1001\/jamapediatrics.2018.0030.","journal-title":"JAMA Pediatr"},{"issue":"6","key":"589_CR8","doi-asserted-by":"publisher","first-page":"e38998","DOI":"10.1371\/journal.pone.0038998","volume":"7","author":"JM Orenstein","year":"2012","unstructured":"Orenstein JM, Shulman ST, Fox LM, Baker SC, Takahashi M, Bhatti TR, et al. Three linked vasculopathic processes characterize Kawasaki disease: a light and transmission electron microscopic study. PLoS One. 2012;7(6):e38998. https:\/\/doi.org\/10.1371\/journal.pone.0038998.","journal-title":"PLoS One"},{"issue":"20","key":"589_CR9","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1161\/CIRCULATIONAHA.111.082107","volume":"125","author":"LB Daniels","year":"2012","unstructured":"Daniels LB, Tjajadi MS, Walford HH, Jimenez-Fernandez S, Trofimenko V, Fick DB Jr, et al. Prevalence of Kawasaki disease in young adults with suspected myocardial ischemia. Circulation. 2012;125(20):2447\u201353. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.111.082107.","journal-title":"Circulation."},{"issue":"7","key":"589_CR10","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1007\/s10067-018-3977-6","volume":"37","author":"Y Tang","year":"2018","unstructured":"Tang Y, Yan W, Sun L, Xu Q, Ding Y, Lv H. Coronary artery aneurysm regression after Kawasaki disease and associated risk factors: a 3-year follow-up study in East China. Clin Rheumatol. 2018;37(7):1945\u201351. https:\/\/doi.org\/10.1007\/s10067-018-3977-6.","journal-title":"Clin Rheumatol"},{"issue":"6","key":"589_CR11","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1007\/s00431-019-03492-8","volume":"179","author":"L Liu","year":"2020","unstructured":"Liu L, Luo C, Hua Y, Wu M, Shao S, Liu X, et al. Risk factors associated with progression and persistence of small- and medium-sized coronary artery aneurysms in Kawasaki disease: a prospective cohort study. Eur J Pediatr. 2020;179(6):891\u2013900. https:\/\/doi.org\/10.1007\/s00431-019-03492-8.","journal-title":"Eur J Pediatr"},{"issue":"4","key":"589_CR12","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1002\/ccd.24486","volume":"81","author":"K Waki","year":"2013","unstructured":"Waki K, Arakaki Y, Mitsudo K. Long-term outcome of transcatheter polytetrafluoroethylene-covered stent implantation in a giant coronary aneurysm of a child with Kawasaki disease. Catheter Cardiovasc Interv. 2013;81(4):713\u20136. https:\/\/doi.org\/10.1002\/ccd.24486.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"4","key":"589_CR13","doi-asserted-by":"publisher","first-page":"516","DOI":"10.4070\/kcj.2016.0163","volume":"47","author":"JS Bang","year":"2017","unstructured":"Bang JS, Kim GB, Kwon BS, Song MK, An HS, Song YW, et al. Long-term prognosis for patients with Kawasaki disease complicated by large coronary aneurysm (diameter >\/=6 mm). Korean Circ J. 2017;47(4):516\u201322. https:\/\/doi.org\/10.4070\/kcj.2016.0163.","journal-title":"Korean Circ J"},{"issue":"1","key":"589_CR14","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1007\/s00246-012-0409-2","volume":"34","author":"A McNeal-Davidson","year":"2013","unstructured":"McNeal-Davidson A, Fournier A, Scuccimarri R, Dancea A, Houde C, Bellavance M, et al. The fate and observed management of giant coronary artery aneurysms secondary to Kawasaki disease in the province of Quebec: the complete series since 1976. Pediatr Cardiol. 2013;34(1):170\u20138. https:\/\/doi.org\/10.1007\/s00246-012-0409-2.","journal-title":"Pediatr Cardiol"},{"key":"589_CR15","doi-asserted-by":"publisher","first-page":"e011319","DOI":"10.1161\/JAHA.118.011319","volume":"8","author":"MBF Son","year":"2019","unstructured":"Son MBF, Gauvreau K, Tremoulet AH, Lo M, Baker AL, de Ferranti S, et al. Risk model development and validation for prediction of coronary artery aneurysms in Kawasaki disease in a north American population. J Am Heart Assoc. 2019;8:e011319.","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"589_CR16","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3345\/kjp.2018.07052","volume":"62","author":"SK Jeon","year":"2019","unstructured":"Jeon SK, Kim G, Ko H, Byun JH, Lee HD. Risk factors for the occurrence and persistence of coronary aneurysms in Kawasaki disease. Korean J Pediatr. 2019;62(4):138\u201343. https:\/\/doi.org\/10.3345\/kjp.2018.07052.","journal-title":"Korean J Pediatr"},{"issue":"10","key":"589_CR17","doi-asserted-by":"publisher","first-page":"e397","DOI":"10.1097\/INF.0b013e31829dd45e","volume":"32","author":"Y Ruan","year":"2013","unstructured":"Ruan Y, Ye B, Zhao X. Clinical characteristics of Kawasaki syndrome and the risk factors for coronary artery lesions in China. Pediatr Infect Dis J. 2013;32(10):e397\u2013402. https:\/\/doi.org\/10.1097\/INF.0b013e31829dd45e.","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"589_CR18","doi-asserted-by":"publisher","first-page":"189","DOI":"10.2188\/jea.JE20140128","volume":"25","author":"M Kuwabara","year":"2015","unstructured":"Kuwabara M, Yashiro M, Kotani K, Tsuboi S, Ae R, Nakamura Y, et al. Cardiac lesions and initial laboratory data in Kawasaki disease: a nationwide survey in Japan. J Epidemiol. 2015;25(3):189\u201393. https:\/\/doi.org\/10.2188\/jea.JE20140128.","journal-title":"J Epidemiol"},{"issue":"8","key":"589_CR19","doi-asserted-by":"publisher","first-page":"e319","DOI":"10.1097\/INF.0b013e31828e887f","volume":"32","author":"P Fu","year":"2013","unstructured":"Fu P, Du Z, Pan Y. Novel predictors of intravenous immunoglobulin resistance in Chinese children with Kawasaki disease. Pediatr Infect Dis J. 2013;32(8):e319\u201323. https:\/\/doi.org\/10.1097\/INF.0b013e31828e887f.","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"589_CR20","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1002\/art.37815","volume":"65","author":"Y Wang","year":"2013","unstructured":"Wang Y, Wang W, Gong F, Fu S, Zhang Q, Hu J, et al. Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1\/Th2 cytokine profiles in patients with Kawasaki disease. Arthritis Rheum. 2013;65(3):805\u201314. https:\/\/doi.org\/10.1002\/art.37815.","journal-title":"Arthritis Rheum"},{"key":"589_CR21","doi-asserted-by":"publisher","unstructured":"Friedman KG, Gauvreau K, Hamaoka-Okamoto A, Tang A, Berry E, Tremoulet AH, et al. Coronary artery aneurysms in Kawasaki disease: risk factors for progressive disease and adverse cardiac events in the US population. J Am Heart Assoc. 2016;5(9). https:\/\/doi.org\/10.1161\/JAHA.116.003289.","DOI":"10.1161\/JAHA.116.003289"},{"issue":"10","key":"589_CR22","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.jfma.2017.07.001","volume":"116","author":"PT Chen","year":"2017","unstructured":"Chen PT, Lin MT, Chen YS, Chen SJ, Wu MH. Computed tomography predict regression of coronary artery aneurysm in patients with Kawasaki disease. J Formos Med Assoc. 2017;116(10):806\u201314. https:\/\/doi.org\/10.1016\/j.jfma.2017.07.001.","journal-title":"J Formos Med Assoc"},{"issue":"2","key":"589_CR23","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jpeds.2006.03.050","volume":"149","author":"K Egami","year":"2006","unstructured":"Egami K, Muta H, Ishii M, Suda K, Sugahara Y, Iemura M, et al. Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease. J Pediatr. 2006;149(2):237\u201340. https:\/\/doi.org\/10.1016\/j.jpeds.2006.03.050.","journal-title":"J Pediatr"},{"issue":"22","key":"589_CR24","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1161\/CIRCULATIONAHA.105.592865","volume":"113","author":"T Kobayashi","year":"2006","unstructured":"Kobayashi T, Inoue Y, Takeuchi K, Okada Y, Tamura K, Tomomasa T, et al. Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease. Circulation. 2006;113(22):2606\u201312. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.105.592865.","journal-title":"Circulation."},{"issue":"3","key":"589_CR25","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1097\/INF.0000000000002563","volume":"39","author":"R Ae","year":"2020","unstructured":"Ae R, Abrams JY, Maddox RA, Schonberger LB, Nakamura Y, Shindo A, et al. Platelet count variation and risk for coronary artery abnormalities in Kawasaki disease. Pediatr Infect Dis J. 2020;39(3):197\u2013203. https:\/\/doi.org\/10.1097\/INF.0000000000002563.","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"589_CR26","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.gendis.2019.09.003","volume":"7","author":"K Arora","year":"2020","unstructured":"Arora K, Guleria S, Jindal AK, Rawat A, Singh S. Platelets in Kawasaki disease: is this only a numbers game or something beyond? Genes Dis. 2020;7(1):62\u20136. https:\/\/doi.org\/10.1016\/j.gendis.2019.09.003.","journal-title":"Genes Dis"},{"issue":"4","key":"589_CR27","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1080\/00325481.2018.1468712","volume":"130","author":"H Qiu","year":"2018","unstructured":"Qiu H, He Y, Rong X, Ren Y, Pan L, Chu M, et al. Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status. Postgrad Med. 2018;130(4):442\u20137. https:\/\/doi.org\/10.1080\/00325481.2018.1468712.","journal-title":"Postgrad Med"},{"issue":"2","key":"589_CR28","doi-asserted-by":"publisher","first-page":"e291","DOI":"10.1542\/peds.2011-1704","volume":"129","author":"H Muta","year":"2012","unstructured":"Muta H, Ishii M, Yashiro M, Uehara R, Nakamura Y. Late intravenous immunoglobulin treatment in patients with Kawasaki disease. Pediatrics. 2012;129(2):e291\u20137. https:\/\/doi.org\/10.1542\/peds.2011-1704.","journal-title":"Pediatrics."},{"key":"589_CR29","doi-asserted-by":"publisher","unstructured":"Son MBF, Gauvreau K, Kim S, Tang A, Dedeoglu F, Fulton DR, et al. Predicting coronary artery aneurysms in Kawasaki disease at a north American center: An assessment of baseline z scores. J Am Heart Assoc. 2017;6(6). https:\/\/doi.org\/10.1161\/JAHA.116.005378.","DOI":"10.1161\/JAHA.116.005378"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-021-00589-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12969-021-00589-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-021-00589-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T21:16:52Z","timestamp":1624742212000},"score":1,"resource":{"primary":{"URL":"https:\/\/ped-rheum.biomedcentral.com\/articles\/10.1186\/s12969-021-00589-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,26]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["589"],"URL":"https:\/\/doi.org\/10.1186\/s12969-021-00589-z","relation":{},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,26]]},"assertion":[{"value":"17 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the local ethics committee of The Second Affiliated Hospital and Yuying Children\u2019s Hospital, China. Written informed consent was waived due to the retrospective nature of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"96"}}